Related Experiment Video
Updated: May 8, 2026

Fentanyl Analog Screening using LC-TIMS-TOF MS/MS
Published on: November 8, 2024
Methadone and Torsades de Pointes: A Case Series
Methadone treatment for opioid use disorder can cause dangerous heart rhythm problems like QT prolongation and Torsades de Pointes. Management involves dose adjustment, switching medications, or cardiac therapies to balance safety and treatment.
Area of Science:
- Cardiology
- Psychiatry
- Pharmacology
Background:
- Opioid use disorder (OUD) treatment with methadone is common.
- Methadone is associated with QT interval prolongation and Torsades de Pointes (TdP).
- Balancing OUD treatment efficacy with cardiac safety is crucial.
Purpose of the Study:
- To report three cases of OUD patients on methadone who developed QT prolongation and TdP.
- To analyze patient-specific risk factors, including methadone dosage.
- To review management strategies and outcomes.
Main Methods:
- Case series review of three patients with OUD on methadone.
- Analysis of risk factors for QT prolongation.
- Evaluation of management strategies: methadone dose reduction, buprenorphine transition, antiarrhythmics, ICDs.
- Assessment of post-hospitalization outcomes.
Main Results:
- Three patients on methadone treatment experienced significant QT prolongation and TdP.
- Patient-specific factors, including methadone dose, contributed to cardiac risk.
- Management strategies varied, including dose reduction, medication change, and cardiac interventions.
- Post-hospitalization follow-up assessed outcomes and risks.
Conclusions:
- Careful monitoring and individualized management are essential for patients on methadone.
- Strategies to mitigate cardiac risk must be balanced against the need for stable OUD treatment.
- This case series highlights the importance of managing methadone-related cardiac risks.
More Related Videos
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Toxidromes: Clinical Features
Drug Toxicity: Dose-Dependent Reactions
Drug Toxicity: Risk factors
Desensitization and Tachyphylaxis
Several...